• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

麻风病的治疗。

Treatment of leprosy.

作者信息

Kar Hemanta Kumar, Gupta Ruchi

机构信息

Department of Dermatology, STD, and Leprosy, PGIMER & Dr RML Hospital, New Delhi, 110001, India.

Department of Dermatology, STD, and Leprosy, PGIMER & Dr RML Hospital, New Delhi, 110001, India.

出版信息

Clin Dermatol. 2015 Jan-Feb;33(1):55-65. doi: 10.1016/j.clindermatol.2014.07.007.

DOI:10.1016/j.clindermatol.2014.07.007
PMID:25432811
Abstract

Leprosy is a curable disease, having been eliminated from many countries, including India. This has been possible due to the wide availability of effective and safe drugs. Treatment of leprosy has undergone considerable changes over decades, from chaulmoogra oil in 1915 to dapsone monotherapy in 1946, then eventually to multidrug therapy (MDT) in 1982. In the last two decades, reports of resistance to all first-line drugs have appeared in the literature, with the need to conduct clinical trials using newer but highly bactericidal drugs and their combinations against Mycobacterium leprae.

摘要

麻风病是一种可治愈的疾病,在包括印度在内的许多国家已被消灭。这之所以成为可能,是因为有广泛可得的有效且安全的药物。几十年来,麻风病的治疗发生了相当大的变化,从1915年的大风子油,到1946年的氨苯砜单药治疗,然后最终在1982年发展为联合化疗(MDT)。在过去二十年里,文献中出现了对所有一线药物耐药的报告,因此有必要开展临床试验,使用更新的但具有高度杀菌作用的药物及其组合来对抗麻风分枝杆菌。

相似文献

1
Treatment of leprosy.麻风病的治疗。
Clin Dermatol. 2015 Jan-Feb;33(1):55-65. doi: 10.1016/j.clindermatol.2014.07.007.
2
Multidrug therapy (MDT) and leprosy control.联合化疗与麻风病防治
Indian J Lepr. 1990 Oct-Dec;62(4):448-58.
3
Developing new MDT regimens for MB patients; time to test ROM 12 month regimens globally.为多药耐药结核病患者开发新的多学科治疗方案;是时候在全球范围内测试12个月的ROM治疗方案了。
Lepr Rev. 2012 Sep;83(3):241-4.
4
Dapsone drug resistance in the MDT era.多药联合治疗时代的氨苯砜耐药性。
Int J Lepr Other Mycobact Dis. 2000 Sep;68(3):323-5.
5
A 6 week quadruple drug regimen for the treatment of multibacillary leprosy.
Lepr Rev. 2000 Mar;71(1):43-6. doi: 10.5935/0305-7518.20000006.
6
Relapse as histoid leprosy after receiving multidrug therapy (MDT); a report of three cases.接受多药联合治疗(MDT)后复发为组织样麻风:三例报告
Int J Lepr Other Mycobact Dis. 2000 Sep;68(3):272-6.
7
[Antibacterial chemotherapy in leprosy: principles, objectives and recommendations].[麻风病的抗菌化疗:原则、目标与建议]
Acta Leprol. 1986 Jul-Sep;4(3):355-62.
8
Multidrug therapy in leprosy.麻风病的联合化疗
J Indian Med Assoc. 2006 Dec;104(12):686-8.
9
Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.多药联合疗法治疗多菌型麻风的疗效:对34例接受多药联合方案治疗直至皮肤涂片转阴的多菌型麻风患者的长期随访
Lepr Rev. 2003 Jun;74(2):141-7.
10
Drug resistant-Mycobacterium leprae--results of mouse footpad studies from a laboratory in south India.耐药性麻风杆菌——印度南部某实验室小鼠足垫研究结果
Indian J Lepr. 2002 Oct-Dec;74(4):301-12.

引用本文的文献

1
Leprosy: Comprehensive insights into pathology, immunology, and cutting-edge treatment strategies, integrating nanoparticles and ethnomedicinal plants.麻风病:对病理学、免疫学以及前沿治疗策略的全面见解,融合纳米颗粒与民族药用植物。
Front Pharmacol. 2024 May 16;15:1361641. doi: 10.3389/fphar.2024.1361641. eCollection 2024.
2
Leprosy: treatment, prevention, immune response and gene function.麻风病:治疗、预防、免疫应答和基因功能。
Front Immunol. 2024 Feb 19;15:1298749. doi: 10.3389/fimmu.2024.1298749. eCollection 2024.
3
Natural Ingredients of Transdermal Drug Delivery Systems as Permeation Enhancers of Active Substances through the .
经皮给药系统的天然成分作为活性物质透过皮肤的渗透增强剂。
Mol Pharm. 2023 Jul 3;20(7):3278-3297. doi: 10.1021/acs.molpharmaceut.3c00126. Epub 2023 Jun 6.
4
Drug Delivery Systems on Leprosy Therapy: Moving Towards Eradication?麻风病治疗中的药物递送系统:朝着根除目标迈进?
Pharmaceutics. 2020 Dec 11;12(12):1202. doi: 10.3390/pharmaceutics12121202.
5
Case Report: Rifampicin-Induced Thrombocytopenia in a Patient with Borderline Lepromatous Leprosy.病例报告:利福平致边缘型麻风患者血小板减少症。
Am J Trop Med Hyg. 2020 Oct;103(4):1441-1442. doi: 10.4269/ajtmh.20-0211.
6
Profile of Defaulters and Pattern of Treatment Default among Leprosy Patients at a Tertiary Care Hospital: A 10-Year Analysis.三级护理医院麻风病患者违约者概况及治疗违约模式:一项10年分析
Indian Dermatol Online J. 2020 May 10;11(3):355-360. doi: 10.4103/idoj.IDOJ_393_19. eCollection 2020 May-Jun.
7
DDS promotes longevity through a microbiome-mediated starvation signal.二甲基砜(DDS)通过微生物群介导的饥饿信号促进长寿。
Transl Med Aging. 2019;3:64-69. doi: 10.1016/j.tma.2019.07.001. Epub 2019 Jul 3.
8
The immunology of other mycobacteria: M. ulcerans, M. leprae.其他分支杆菌的免疫学:溃疡分枝杆菌、麻风分枝杆菌。
Semin Immunopathol. 2020 Jun;42(3):333-353. doi: 10.1007/s00281-020-00790-4. Epub 2020 Feb 25.
9
World Health Organization (WHO) antibiotic regimen against other regimens for the treatment of leprosy: a systematic review and meta-analysis.世界卫生组织(WHO)抗麻风病抗生素方案与其他方案的比较:系统评价和荟萃分析。
BMC Infect Dis. 2020 Jan 20;20(1):62. doi: 10.1186/s12879-019-4665-0.
10
Stability of Dapsone in Extemporaneously Compounded Oral Suspensions.氨苯砜在临时配制口服混悬液中的稳定性。
Can J Hosp Pharm. 2018 Mar-Apr;71(2):152-154. Epub 2018 Apr 30.